Cargando…
LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling
Temporomandibular joint OA (TMJOA) is a common degenerative joint disease, leads to structural damage and ultimately loss of function. Matrix degradation is one of the first pathogenesis during the progression of OA, it was effective to inhibit matrix degradation to block the development of OA. In t...
Autores principales: | Zhang, Caixia, Zhu, Mengjiao, Wang, Huijuan, Wen, Juan, Huang, Ziwei, Chen, Sheng, Zhao, Hongting, Li, Huang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382747/ https://www.ncbi.nlm.nih.gov/pubmed/34426599 http://dx.doi.org/10.1038/s41598-021-96348-x |
Ejemplares similares
-
LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
por: Yuan, Ruiyan, et al.
Publicado: (2021) -
LOXL2 as a protective in osteoarthritis cartilage
por: Bais, Manish V., et al.
Publicado: (2017) -
IL-32γ attenuates airway fibrosis by modulating the integrin-FAK signaling pathway in fibroblasts
por: Hong, Gyong Hwa, et al.
Publicado: (2018) -
Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3
por: Visavadiya, Nishant P., et al.
Publicado: (2016) -
Erratum to: Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3
por: Visavadiya, Nishant P., et al.
Publicado: (2017)